# BVS (Bioventus Inc.) - SEC EDGAR Financial Statements

> Bioventus Inc. reported $585.6M in revenue and net income of $57.30M for the trailing twelve months ended September 26, 2026 (up 2.7% year over year), with a 68.7% gross margin and a 9.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/BVS
- Markdown: https://convexityos.com/fundamentals/BVS.md
- SEC CIK: 0001665988
- Reporting currency: USD
- Latest filing period: September 26, 2026
- Last synced: Nov 20, 2026, 05:32 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001665988&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $585.6M | +2.7% YoY |
| Operating Income | TTM | $56.73M | 9.7% margin |
| Net Income | TTM | $57.30M | 9.8% net margin |
| Diluted EPS | TTM | $0.79 | Split-adjusted |
| Free Cash Flow | TTM | $84.98M | 14.5% FCF margin |
| Cash & ST Investments | Sep 26, 2026 | $30.71M | Total debt: $244.2M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $568.1M | $573.3M | $512.3M | $512.1M | $430.9M | $321.2M | $340.1M |
| Cost of Revenue | $179.9M | $185.1M | $184.2M | $181.0M | $128.2M | $87.64M | $90.94M |
| **Gross Profit** | $388.2M | $388.2M | $328.2M | $331.1M | $302.7M | $233.5M | $249.2M |
| Research & Development | $12.11M | $13.95M | $13.45M | $23.85M | $19.04M | $11.20M | $11.05M |
| Selling, General & Admin | $314.0M | $343.8M | $303.9M | $332.1M | $254.3M | $193.1M | $198.5M |
| **Operating Income** | $53.98M | -$15.20M | -$81.72M | -$167.2M | $12.06M | $21.24M | $31.19M |
| **EBITDA** | $101.0M | $34.36M | -$24.36M | -$111.8M | $46.94M | $49.88M | $61.51M |
| Income Before Tax | $25.71M | -$52.34M | -$121.1M | -$189.0M | $9.49M | $15.91M | $9.69M |
| Income Tax Expense | -$1.56M | -$5.29M | $85K | -$44.37M | -$1.97M | $1.19M | $1.58M |
| **Net Income** | $22.73M | -$36.12M | -$156.2M | -$158.7M | $19.38M | $16.41M | $6.85M |
| Basic EPS | $0.34 | -$0.56 | -$2.49 | -$2.59 | -$0.15 | -- | -- |
| **Diluted EPS** | $0.33 | -$0.56 | -$2.49 | -$2.59 | -$0.15 | -- | -- |
| Basic Shares Outstanding | 66.6M | 64.5M | 62.6M | 61.4M | 45.5M | -- | -- |
| Diluted Shares Outstanding | 68.9M | 64.5M | 62.6M | 61.4M | 45.5M | -- | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $142.4M | $153.2M | $132.1M | $157.9M | $138.7M | $147.7M | $123.9M | $153.6M |
| Cost of Revenue | $45.31M | $47.54M | $41.32M | $49.12M | $44.42M | $45.57M | $40.82M | $50.99M |
| **Gross Profit** | $97.13M | $105.7M | $90.77M | $108.8M | $94.23M | $102.1M | $83.06M | $102.7M |
| Research & Development | $3.44M | $3.17M | $2.47M | $3.01M | $2.92M | $3.17M | $3.01M | $3.27M |
| Selling, General & Admin | $82.94M | $82.74M | $78.33M | $82.76M | $78.66M | $79.11M | $73.50M | $86.87M |
| **Operating Income** | $9.70M | $19.13M | $8.42M | $19.49M | $11.25M | $18.37M | $4.87M | $7.70M |
| **EBITDA** | $20.02M | $30.07M | $19.62M | $31.18M | $22.66M | $30.42M | $16.73M | $20.11M |
| Income Before Tax | $6.16M | $15.31M | $4.52M | $14.14M | $4.67M | $10.31M | -$3.42M | -$53K |
| Income Tax Expense | -$701K | -$20.90M | $571K | -$3.17M | $664K | $1.04M | -$95K | $550K |
| **Net Income** | $5.99M | $33.44M | $3.11M | $14.76M | $3.15M | $7.46M | -$2.64M | -$388K |
| Basic EPS | $0.09 | $0.49 | $0.05 | -- | $0.05 | $0.11 | -$0.04 | -- |
| **Diluted EPS** | $0.08 | $0.47 | $0.04 | -- | $0.05 | $0.11 | -$0.04 | -- |
| Basic Shares Outstanding | 68.4M | 67.9M | 67.3M | -- | 66.9M | 66.5M | 66.0M | -- |
| Diluted Shares Outstanding | 72.5M | 70.8M | 70.0M | -- | 68.8M | 68.5M | 66.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $51.24M | $41.58M | $36.96M | $30.19M | $43.93M | $86.84M |
| **Cash & Short-Term Investments** | $51.24M | $41.58M | $36.96M | $30.19M | $43.93M | $86.84M |
| Accounts Receivable, Net | $128.3M | $127.4M | $122.8M | $136.3M | $125.0M | $88.28M |
| Inventory | $82.24M | $92.47M | $91.33M | $84.77M | $61.69M | $29.12M |
| **Total Current Assets** | $272.8M | $275.6M | $268.0M | $272.6M | $263.1M | $211.8M |
| Property, Plant & Equipment, Net | $21.90M | $27.01M | $36.60M | $27.65M | $22.98M | $6.88M |
| Goodwill | $7.46M | $7.46M | $7.46M | $7.46M | $147.6M | $49.80M |
| Intangible Assets | $368.4M | $404.7M | $482.4M | $639.9M | $695.2M | $191.7M |
| Long-Term Investments | $2.29M | $1.89M | $3.14M | $2.62M | $29.29M | $19.38M |
| **Total Non-Current Assets** | $410.7M | $452.3M | $542.9M | $1.10B | $962.8M | $282.7M |
| **Total Assets** | $683.6M | $728.0M | $810.9M | $1.37B | $1.23B | $494.5M |
| Accounts Payable | $10.93M | $23.69M | $23.04M | $36.70M | $16.91M | $4.42M |
| Short-Term Debt | $15.00M | $27.34M | $27.85M | $33.06M | $18.04M | $15.00M |
| Deferred Revenue (Current) | $955K | $1.68M | $2.35M | $2.90M | $2.40M | $0 |
| Other Current Liabilities | $4.21M | $3.92M | $4.82M | $3.61M | $3.56M | $3.93M |
| **Total Current Liabilities** | $160.4M | $210.4M | $175.5M | $304.0M | $180.9M | $122.6M |
| Long-Term Debt | $279.0M | $308.3M | $367.0M | $385.0M | $339.6M | $173.4M |
| Other Non-Current Liabilities | $15.35M | $23.10M | $27.93M | $22.81M | $21.72M | $21.73M |
| **Total Non-Current Liabilities** | $294.7M | $332.0M | $414.3M | $656.4M | $437.3M | $227.7M |
| **Total Liabilities** | $455.1M | $542.4M | $589.8M | $960.4M | $618.2M | $350.3M |
| **Total Debt (incl. Leases)** | $311.3M | $356.1M | $420.6M | $436.1M | $376.2M | $204.4M |
| Retained Earnings | -$334.9M | -$357.7M | -$321.5M | -$165.3M | -$6.60M | -- |
| Accumulated Other Comp. Income | -$1.90M | -$2.57M | $794K | -$110K | $179K | -- |
| **Total Stockholders' Equity** | $184.1M | $147.9M | $173.6M | $325.2M | $458.9M | -- |
| Total Equity | $228.4M | $185.6M | $221.1M | $412.2M | $607.7M | -- |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $30.71M | $29.46M | $35.85M | $51.24M | $42.16M | $32.91M | $22.80M | $41.58M |
| **Cash & Short-Term Investments** | $30.71M | $29.46M | $35.85M | $51.24M | $42.16M | $32.91M | $22.80M | $41.58M |
| Accounts Receivable, Net | $138.2M | $138.4M | $120.5M | $128.3M | $130.4M | $132.4M | $118.1M | $127.4M |
| Inventory | $83.10M | $79.81M | $83.19M | $82.24M | $96.27M | $96.47M | $94.05M | $92.47M |
| **Total Current Assets** | $265.5M | $257.5M | $249.8M | $272.8M | $280.9M | $275.2M | $249.4M | $275.6M |
| Property, Plant & Equipment, Net | $19.78M | $20.53M | $21.29M | $21.90M | $22.98M | $24.51M | $25.72M | $27.01M |
| Goodwill | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M |
| Intangible Assets | $343.9M | $351.0M | $359.7M | $368.4M | $377.4M | $387.0M | $395.7M | $404.7M |
| Long-Term Investments | $3.42M | $3.51M | $2.10M | $2.29M | $2.27M | $1.69M | $1.76M | $1.89M |
| **Total Non-Current Assets** | $407.9M | $415.8M | $400.7M | $410.7M | $420.7M | $431.6M | $442.0M | $452.3M |
| **Total Assets** | $673.4M | $673.3M | $650.5M | $683.6M | $701.6M | $706.8M | $691.4M | $728.0M |
| Accounts Payable | $25.79M | $20.20M | $24.05M | $10.93M | $26.65M | $24.25M | $19.20M | $23.69M |
| Short-Term Debt | $18.75M | $18.75M | $18.75M | $15.00M | $11.25M | $43.36M | $37.34M | $27.34M |
| Deferred Revenue (Current) | -- | -- | -- | $955K | -- | -- | -- | $1.68M |
| Other Current Liabilities | $4.14M | $4.14M | $4.16M | $4.21M | $4.41M | $4.41M | $4.36M | $3.92M |
| **Total Current Liabilities** | $157.7M | $152.5M | $148.1M | $160.4M | $161.8M | $185.7M | $174.8M | $210.4M |
| Long-Term Debt | $211.1M | $229.7M | $253.3M | $279.0M | $311.3M | $297.9M | $308.6M | $308.3M |
| Other Non-Current Liabilities | $12.21M | $13.21M | $14.29M | $15.35M | $20.47M | $21.28M | $21.98M | $23.10M |
| **Total Non-Current Liabilities** | $223.9M | $243.5M | $268.2M | $294.7M | $332.6M | $319.8M | $331.2M | $332.0M |
| **Total Liabilities** | $381.6M | $395.9M | $416.3M | $455.1M | $494.3M | $505.5M | $505.9M | $542.4M |
| **Total Debt (incl. Leases)** | $244.2M | $263.7M | $288.4M | $311.3M | $341.2M | $360.7M | $366.1M | $356.1M |
| Retained Earnings | -$292.4M | -$298.4M | -$331.8M | -$334.9M | -$349.7M | -$352.8M | -$360.3M | -$357.7M |
| Accumulated Other Comp. Income | -$148K | -$1.33M | -$2.28M | -$1.90M | -$1.84M | -$774K | -$2.06M | -$2.57M |
| **Total Stockholders' Equity** | $240.5M | $228.3M | $188.9M | $184.1M | $166.1M | $161.2M | $148.1M | $147.9M |
| Total Equity | $291.9M | $277.4M | $234.3M | $228.4M | $207.3M | $201.3M | $185.5M | $185.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $27.27M | -$47.05M | -$195.6M | -$213.4M | $9.59M | $14.72M | $6.30M |
| Depreciation & Amortization | $47.01M | $49.55M | $57.37M | $55.40M | $34.88M | $28.64M | $30.32M |
| Stock-Based Compensation | $12.67M | $13.27M | $2.72M | $17.59M | $19.84M | $0 | $0 |
| Change in Receivables | -$916K | -$10.67M | $10.05M | -$17.67M | -$20.05M | -$3.94M | -$14.91M |
| Change in Inventory | $8.57M | -$16.43M | -$5.99M | -$18.62M | $3.18M | -$528K | -$1.43M |
| **Operating Cash Flow** | $74.67M | $38.80M | $15.34M | -$13.54M | $22.99M | $71.80M | $40.71M |
| Capital Expenditure | -$2.56M | -$1.01M | -$7.36M | -$1.48M | -$13.52M | -$16.58M | -$2.34M |
| **Free Cash Flow** | $72.11M | $37.79M | $7.98M | -$15.02M | $9.47M | $55.22M | $38.37M |
| Acquisitions, Net | -- | -- | -- | -- | -$262.9M | $0 | $430K |
| Purchases of Investments | -- | -- | -- | -- | -$13.52M | -$16.58M | -$6.00M |
| **Investing Cash Flow** | -$3.25M | $22.96M | $15.81M | -$116.4M | -$283.8M | -$20.50M | -$7.91M |
| Common Stock Issued | $2.07M | $2.44M | $778K | $5.82M | $1.63M | $0 | $0 |
| **Financing Cash Flow** | -$62.14M | -$54.58M | -$26.65M | $62.08M | $273.4M | -$29.57M | -$10.95M |
| **Net Change in Cash** | $9.66M | $4.62M | $5.13M | -$67.38M | $12.37M | $22.32M | $21.75M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $6.86M | $36.20M | $3.95M | $17.32M | $4.01M | $9.27M | -$3.32M | -$603K |
| Depreciation & Amortization | $10.31M | $10.95M | $11.21M | $11.69M | $11.40M | $12.05M | $11.87M | $12.40M |
| Stock-Based Compensation | $4.76M | $5.04M | $3.26M | $3.44M | $3.18M | $3.64M | $2.41M | $2.02M |
| Change in Receivables | $152K | -$17.94M | $7.32M | $1.89M | $1.82M | -$13.63M | $9.00M | -$5.79M |
| Change in Inventory | -$3.53M | $2.96M | -$2.65M | $12.97M | $291K | -$2.81M | -$1.88M | -$5.56M |
| **Operating Cash Flow** | $20.66M | $19.87M | $8.93M | $37.97M | $30.10M | $25.94M | -$19.33M | $19.32M |
| Capital Expenditure | -$334K | -$960K | -$574K | -$580K | -$473K | -$683K | -$826K | -$574K |
| **Free Cash Flow** | $20.32M | $18.91M | $8.36M | $37.39M | $29.62M | $25.25M | -$20.16M | $18.75M |
| **Investing Cash Flow** | -$1.83M | -$2.46M | -$574K | -$580K | -$473K | -$1.37M | -$826K | $24.10M |
| Common Stock Issued | $1.42M | $853K | $120K | $511K | $96K | $1.32M | $150K | $1.10M |
| **Financing Cash Flow** | -$17.58M | -$23.43M | -$23.14M | -$28.45M | -$19.98M | -$14.66M | $947K | -$42.85M |
| **Net Change in Cash** | $1.25M | -$6.39M | -$15.39M | $9.07M | $9.25M | $10.11M | -$18.78M | -$1.49M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 68.3% | 67.7% | 64.1% | 64.6% | 70.3% | 72.7% | 73.3% |
| **Operating Margin** | 9.5% | -2.7% | -16.0% | -32.7% | 2.8% | 6.6% | 9.2% |
| **Net Profit Margin** | 4.0% | -6.3% | -30.5% | -31.0% | 4.5% | 5.1% | 2.0% |
| Return on Equity (ROE) | 12.3% | -24.4% | -90.0% | -48.8% | 4.2% | -- | -- |
| Return on Assets (ROA) | 3.3% | -5.0% | -19.3% | -11.6% | 1.6% | 3.3% | -- |
| Current Ratio | 1.70x | 1.31x | 1.53x | 0.90x | 1.45x | 1.73x | -- |
| Quick Ratio | 1.19x | 0.87x | 1.01x | 0.62x | 1.11x | 1.49x | -- |
| Debt to Equity | 1.69x | 2.41x | 2.42x | 1.34x | 0.82x | -- | -- |
| **Revenue Growth (YoY)** | -0.9% | +11.9% | 0.0% | +18.8% | +34.2% | -5.6% | -- |
| Gross Profit Growth (YoY) | 0.0% | +18.3% | -0.9% | +9.4% | +29.6% | -6.3% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -1486.6% | -43.2% | -31.9% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -919.1% | +18.1% | +139.5% | -- |
| Operating Cash Flow Growth (YoY) | +92.5% | +152.8% | -- | -158.9% | -68.0% | +76.4% | -- |
| Free Cash Flow Growth (YoY) | +90.8% | +373.4% | -- | -258.5% | -82.8% | +43.9% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 68.7% | 68.7% | 68.7% | 68.3% | 67.8% | 67.6% | 67.4% | 67.7% |
| **Operating Margin** | 9.7% | 10.0% | 10.0% | 9.5% | 7.5% | 6.1% | -2.7% | -2.7% |
| **Net Profit Margin** | 9.8% | 9.4% | 4.9% | 4.0% | 1.3% | -0.1% | -6.0% | -6.3% |
| Return on Equity (ROE) | 23.8% | 23.9% | 15.1% | 12.3% | 4.6% | -0.5% | -22.9% | -24.4% |
| Return on Assets (ROA) | 8.5% | 8.1% | 4.4% | 3.3% | 1.1% | -0.1% | -4.9% | -5.0% |
| Current Ratio | 1.68x | 1.69x | 1.69x | 1.70x | 1.74x | 1.48x | 1.43x | 1.31x |
| Quick Ratio | 1.16x | 1.17x | 1.13x | 1.19x | 1.14x | 0.96x | 0.89x | 0.87x |
| Debt to Equity | 1.02x | 1.16x | 1.53x | 1.69x | 2.05x | 2.24x | 2.47x | 2.41x |
| **Revenue Growth (YoY)** | +2.7% | +3.8% | +6.6% | +2.8% | -0.2% | -2.4% | -4.3% | +13.5% |
| Gross Profit Growth (YoY) | +3.1% | +3.5% | +9.3% | +6.0% | +0.7% | -1.5% | -6.0% | +19.0% |
| Operating Income Growth (YoY) | -13.8% | +4.1% | +72.8% | +153.0% | +208.5% | -- | -1.2% | +561.2% |
| **Net Income Growth (YoY)** | +89.8% | +348.3% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | +80.0% | +345.5% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -31.4% | -23.4% | -- | +96.5% | +191.8% | +71.1% | -- | +86.3% |
| Free Cash Flow Growth (YoY) | -31.4% | -25.1% | -- | +99.4% | +189.0% | +67.4% | -- | +87.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
